IP Library Granted Patent US 8,309,143
Granted Patent B2
US 8,309,143 · App. 12/762,094 · Granted Nov 13, 2012

Hair and scalp care formulations for treating and preventing acne and related skin conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,309,143
App. No.
12/762,094
Granted
Nov 13, 2012
Kind
B2
Abstract

The present invention is directed to skin treatment formulations having salicylic acid and other secondary ingredients. The secondary ingredients may include: non-comedogenic essential oils and plant extracts and sebum reducing agents. Salicylic acid and the secondary ingredients are provided in amounts effective to provide a sufficiently aggressive skin treatment for unclogging pores and reducing inflammation, while maintaining levels of sebum on the exterior of the skin to form an operative water barrier on the skin and hair. Additionally, a method is provided that unclogs pores, reduces inflammation, and controls levels of sebum on the exterior of the skin to maintain an operative water barrier on the skin and hair. The method may include, applying a sufficiently aggressive product comprising salicylic acid, non-comedogenic plant extracts and essential oils, and a sebum reducing agent to hair and its surrounding areas.

Claims (7)

1. A method for treating acne, wherein the acne is face, neck, chest, shoulder, upper arm or back acne, comprising administering to hair and scalp of a subject in need of such treatment a topical non-comedogenic and non-sebum producing composition comprising salicylic acid in the range of about 0.5% to 2.0% w/w, sweet almond oil in the range of about 0.5% to 30% w/w, tea tree oil in the range of about 0.1% to 1.0% w/w, lavender oil in the range of about 0.1% to 1.0% w/w, Iris Florentina root extract in the range of about 0.1% to 10% w/w, Sapindus Mukurossi fruit extract in the range of about 0.1% to 1.0% w/w, Anthemis Nobilis flower extract in the range of about 0.1% to 1.0% w/w, and copper PCA in the range of about 0.1% to 1.0% w/w.

2. The method of claim 1 , wherein salicylic acid is present in an amount of about 1.0% w/w.

3. The method of claim 2 , wherein the composition further comprises retinyl palmitate is present in an amount of about 0.1% to 1.0% and zinc sulfate in an amount of about 0.1% to 10% w/w.

4. The method of claim 1 , wherein the composition further comprises lactic acid.

5. The method of claim 4 , wherein lactic acid is present in the range of about 0.1% to 10% w/w.

6. The method of claim 4 , wherein the composition further comprises retinyl palmitate and benzalkonium chloride.

7. The method of claim 6 , wherein retinyl palmitate is present in the range of about 0.1% to 1.0% w/w and benzalkonium chloride is present in the range of about 0.1 to 1.0% w/w.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2016
From: CAMPBELL, DOREEN; PARKER, CATHERINE
To: CLEARSKIN RX, INC.
Reel/Frame 040183/0053 →
Continuity (1)
Related Publication 20110256249A1 · Oct 20, 2011